EXPORT randomized trial for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new way to treat persistent atrial fibrillation (a type of irregular heartbeat) during your first catheter ablation procedure. The goal is to see if this approach offers better results than the usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have persistent atrial fibrillation and are scheduled for your first catheter ablation.
- You have tried at least one heart rhythm medication (like a class I or III drug) and it didn't work or you couldn't take it.
- You have not had a stroke or mini-stroke in the last 3 months.
- You don't have severe heart disease, such as a recent heart attack, severe valve problems, or very high blood pressure.
- You are not pregnant.
- You have no other serious medical conditions that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new way to find and treat the specific areas in the heart that cause atrial fibrillation to come back. It aims to improve the success of a repeat ablation procedure for people whose previous pulmonary vein isolation did not stop the irregular heartbeats.
This trial tests a new type of catheter ablation (using heat to create scar lines in the heart) for people with persistent atrial fibrillation who have a higher risk of stroke or bleeding. It aims to see if this approach can help prevent strokes and reduce the need for long-term blood thinners.
This trial tests whether one ablation approach works better than another for paroxysmal (intermittent) atrial fibrillation by targeting the heart’s “triggers” and “substrate” (where the rhythm problem is). If you qualify, you’ll be randomly assigned to one of two ablation energy methods during a pulmonary vein isolation procedure.
This study compares two types of ablation (a procedure that uses energy to fix irregular heartbeats) for people with persistent atrial fibrillation. It tests whether adding extra treatment to the back of the heart's left upper chamber helps improve outcomes compared to standard treatment alone.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.